Once-Weekly, High-Dose Stereotactic Body Radiotherapy for Lung Cancer: 6-Year Analysis of 60 Early-Stage, 42 Locally Advanced, and 7 Metastatic Lung Cancers

International Journal of Radiation Oncology Biology Physics

Volumn 72, Issue 3, 2008, Pages 707-715

  Salazar, Omar M ^a   Sandhu, Taljit S ^a   Lattin, Paul B ^a   Chang, Jung H ^a   Lee, Choon K ^a   Groshko, Gayle A ^a   Lattin, Cheryl J ^a  

^a Oakwood Healthcare Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL ORGANS; ELECTROTHERAPEUTICS; ONCOLOGY; RADIOTHERAPY; TUMORS;

BIOLOGICALLY EFFECTIVE DOSE; HIGH-DOSE; ISOCENTER; LUNG CANCERS; METASTATIC LUNG CANCER; METASTATIC TUMORS; PATIENT AGE; PLANNING TARGET VOLUME; STAGE III; STEREOTACTIC BODY RADIOTHERAPY; TOTAL-DOSE;

STAGES;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; METASTASIS; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RADIATION INJURY; STEREOTACTIC TREATMENT; TREATMENT FAILURE; TREATMENT OUTCOME; TREATMENT RESPONSE;

CARCINOMA, NON-SMALL-CELL LUNG; COMBINED MODALITY THERAPY; FOLLOW-UP STUDIES; HUMANS; LUNG NEOPLASMS; NEOPLASM METASTASIS; NEOPLASM STAGING; RADIOSURGERY; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; SURVIVORS; TIME FACTORS;

EID: 52949087182     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2008.01.054     Document Type: Article

References (51)

1. Yancik R., and Ries L.A. Aging and cancer in America: Demographic and epidemiologic perspectives. Hematol Oncol Clin North Am 14 (2000) 17-23
2. Fry W.A., Phillips J.L., and Menck H.R. Ten-year survey on lung cancer treatment and survival in hospitals in the United States: A National Cancer database report. Cancer 86 (1999) 1867-1876
3. Hurria A., and Kris M.G. Management of lung cancer in older adults. CA Cancer J Clin 53 (2000) 325-341
4. Dyzkiewicz W., Pawlak K., and Gasirowski L. Early post-pneumonectomy complications in the elderly. Eur J Cardiothorac Surg 17 (2000) 246-250
5. The International Early Lung Cancer Action Program (I-ELCAP) Investigators. Survival of patients with stage I lung cancer detected on CT screening. N Engl J Med 335 (2006) 1763-1771
6. McGarry R., Song G., DesRosiers P., et al. Observation-only management of early stage, medically inoperable lung cancer. Chest 121 (2002) 1155-1158
7. Sibley G.S., Jamieson T.A., Marks L.B., et al. Radiotherapy alone for medically inoperable Stage I non-small cell lung cancer: The Duke experience. Int J Radiat Ocol Biol Phys 40 (1998) 149-154
8. Dosoretz D.E., Galmarini D., Rubenstein J.H., et al. Local control in medically inoperable lung cancer: An analysis of its importance in outcome and factors determining the probability of tumor eradication. Int J Radiat Oncol Biol Phys 27 (1993) 507-516
9. Bradley J.D., Graham M.V., Winter K.W., et al. Acute and late toxicity results of RTOG 9311: A dose escalation study using 3D conformal radiation therapy in patients with inoperable non-small cell lung cancer. Int J Radiat Oncol Biol Phys 57 2 Suppl. (2003) S137-S138
10. Hayman J.A., Martel M.K., Ten Harken R.K., et al. Dose escalation in non-small cell lung cancer using three-dimensional conformal radiation therapy: Update of a Phase I trial. J Clin Oncol 19 (2001) 127-136
11. Salazar OM. Extracranial stereotactic radiosurgery. Presented at the 13th Annual Meeting of the American College of Radiation Oncology (ACRO)-Emergent Technologies, Phoenix, Arizona, February 27 to March 2, 2003.
12. Salazar O.M., Sandhu T.S., Orton B.G., et al. Treatment of intrathoracic malignancies with once/week (O/W) stereotactic radioablation (SRA), with/without respiration gating (R/G). [Abstract]. Int J Radiat Oncol Biol Phys 60 Suppl (2004) S283
13. Salazar OM. Thoracic extracranial stereotactic radiosurgery. Presented at the 13th Biannual Meeting of the Spanish Association of Radiation Oncology (AERO), Cadiz, Spain, October 4-9, 2005.
14. Salazar OM. Extracranial stereotactic radiosurgery is a potent treatment for primary and metastatic lung tumors. Fields of view of the American College of Radiation Oncology (ACRO). Advance for Imaging and Oncology Administrators. November 2006;16:54-57, 71.
15. Salazar O.M., Van Houtte P., and Rubin P. Once-a-week radiation therapy for locally advanced lung cancer: Final report. Cancer 54 (1984) 719-725
16. Slawson R.G., Salazar O.M., Poussin-Rosillo H., et al. Once a week vs. conventional daily radiation treatment for lung cancer: Final report. Int J Radiat Oncol Biol Phys 15 (1988) 61-68
17. Fowler J.F. The linear-quadratic formula and progress in fractionated radiotherapy: A review. Brit J Radiol 62 (1989) 679-694
18. Therasse P., Arbuck T.P., Eisenhauer E.A., et al. New guidelines to evaluate the response to treatment in solid tumors. J Natl Cancer Inst 92 (2000) 205-216
19. National Cancer Institute. Common terminology criteria for adverse events (CTCAE), version 3.0, June 10 (2003), National Institutes of Health, U.S. Department of Health and Human Services, Bethesda
20. Kaplan E.L., and Meir P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 53 (1958) 457-481
21. Peto R., and Peto J. Asymptotically efficient rank invariant tests procedures (with discussion). J R Stat Soc [A] 135 (1972) 185-207
22. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration: Part I. Cancer Chemother Rep 50 (1966) 163-170
23. Afifi A.A., and Clark V. Regression analysis using survival data. Computer-aided multivariate analysis (1990), Van Nostrand Reinhold, New York 334-370
24. Matthews D.E., and Farewell V. Fisher's test for 2 × 2 contingency tables. Using and understanding medical statistics (1985), Karger, New York 20-26
25. Leksell L. The stereotaxic method and radiosurgery for the brain. Acta Chirug Scand 102 (1951) 316-319
26. Flickinger J.C., Kondoziolka D., Lunsford L.D., et al. A multi-institutional experience with stereotactic radiosurgery for solitary brain metastasis. Int J Radiat Oncol Biol Phys 28 (1994) 797-802
27. Blomgren H., Lax I., Naslund I., et al. Stereotactic high dose fraction radiation therapy of extracranial tumors using an accelerator. Acta Oncol 34 (1995) 861-870
28. Blomgren H., Lax I., Göranson T., et al. Radiosurgery for tumors in the body: Clinical experience using a new method. J Radiosurg 1 (1998) 63-74
29. Uematsu M., Shioda A., Tahara K., et al. Focal high dose and fractionated modified stereotactic radiation therapy for lung carcinoma patients: A preliminary experience. Cancer 82 (1998) 1062-1070
30. Shirato H., Shimizu S., Tadashi S., et al. Real time tumor-tracking radiotherapy. Lancet 353 (1999) 1331-1332
31. Nagata Y., Negoro Y., Aoki T., et al. Clinical outcomes of 3D conformal hypofractionated single high-dose radiotherapy for one or two lung tumors using a stereotactic body frame. Int J Radiat Oncol Biol Phys 52 (2002) 1041-1046
32. Wulf J., Hadinger U., Oppitz U., et al. Stereotactic radiotherapy of targets in the lung and liver. Strahlenther Onkol 177 (2001) 645-655
33. Timmerman R., Papiez L., McGary R., et al. Extracranial stereotactic radioablation: Results of a phase I study in medically inoperable stage I non-small cell lung cancer patients. Chest 124 (2003) 1946-1955
34. Keall P.J., Kini V.R., Vedam S.S., et al. Potential radiotherapy improvements with respiratory gating. Australas Phys Eng Sci Med 25 (2002) 1-6
35. Cheung P.C., Sixel K.E., Tirona R., et al. Reproducibility of lung tumor position and reduction of lung mass within the planning target volume using active breathing control (ABC). Int J Radiat Oncol Biol Phys 53 (2002) 1058-1070
36. Fowler J.F., Tome W.A., and Welsh J.S. On the estimation of required doses in stereotactic body radiation therapy. In: Kavanagh B.D., and Timmerman R.D. (Eds). Stereotactic body radiation therapy (2005), Lippincott, Williams & Wilkins, Philadelphia 7-14
37. Song D.Y., and Blomgren H. Stereotactic body radiotherapy for lung tumors. In: Kavanagh B.D., and Timmerman R.D. (Eds). Stereotactic body radiation therapy (2005), Williams & Wilkins, Philadelphia 99-107
38. Hara R., Itami J., Kondo T., et al. Stereotactic single high dose irradiation of lung tumors under respiratory gating. Radiother Oncol 63 (2002) 159-163
39. Fukimoto S., Shirato H., Shimzu S., et al. Small volume, image-guided radiotherapy using hypofractionated, coplanar and non-coplanar multiple fields for patients with inoperable Stage I non small cell lung carcinomas. Cancer 95 (2002) 1546-1553
40. Timmerman R.D., Papiez I., McGarry R., et al. Extracranial stereotactic radioablation: Results of a phase I study in medically inoperable Stage I non-small cell lung cancer. Chest 124 (2003) 1946-1955
41. Mountain C.F., McMurtry M.J., and Hermes K.E. Surgery for pulmonary metastasis: A 20-year experience. Ann Thorac Surg 38 (1984) 323-330
42. Venn G.E., Sarin S., and Goldstraw P. Survival following pulmonary metastasectomy. Eur J Cardiothorac Surg 3 (1989) 105-110
43. Ishida T., Kaniko S., Yokoyama H., et al. Metastatic lung tumors and extended indications for surgery. Int Surg 77 (1992) 173-177
44. Wright J.O., Brandt B., and Ehrenhaft J.L. Results of pulmonary resection for metastatic lesions. J Thorac Cardiovasc Surg 83 (1982) 94-99
45. Pastorino U., Buyse M., Friedel G., et al. Long-term results of lung metastasectomy: Prognostic analysis based on 5,206 cases. J Thorac Cardiovasc Surg 113 (1997) 37-49
46. Nakagawa K., Aoli Y., Tago M., et al. Megavoltage CT-assisted stereotactic radiosurgery for thoracic tumors: Original research in the treatment of thoracic neoplasms. Int J Radiat Oncol Biol Phys 48 (2000) 449-457
47. Uematsu M., Shioda A., Suda A., et al. Computed tomography-guided frameless stereotactic radiotherapy for stage I non-small cell lung cancer: A 5-year experience. Int J Radiat Oncol Biol Phys 51 (2001) 666-670
48. Nagata Y., Takayama K., Matsuo Y., et al. Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame. Int J Radiat Oncol Biol Phys 63 (2005) 1427-1431
49. Hof H., Herfarth K.K., Monter M., et al. Stereotactic single dose radiotherapy of stage I non-small cell lung cancer. Int J Radiat Oncol Biol Phys 56 (2003) 335-341
50. Onishi Y., Araki T., Shirato H., et al. Stereotactic hypofractionated high-dose irradiation for Stage I non-small cell lung carcinoma: Clinical outcomes is 245 subjects in a Japanese multiinstitutional study. Cancer 101 (2004) 1623-1631
51. Miyamoto T., Masayuki B., Toshio S., et al. Carbon ion radiotherapy for stage I non-small cell lung cancer using a regimen of four fractions during 1 week. J Thorac Oncol 2 (2007) 916-926